1. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation. 2017;135(8):759-71.https://www.ncbi.nlm.nih.gov/pubmed/28052979
2. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. The Lancet Neurology. 2011;10(5):471-80
3. Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immunol. 2007;8(1):11-3.https://www.ncbi.nlm.nih.gov/pubmed/17179963
4. Bune LT, Thaning P, Johansson PI, Bochsen L, Rosenmeier JB. Effects of nucleotides and nucleosides on coagulation. Blood Coagul Fibrinolysis. 2010;21(5):436-41.https://www.ncbi.nlm.nih.gov/pubmed/20389237
5. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov. 2008;7(7):575-90.https://www.ncbi.nlm.nih.gov/pubmed/18591979
6. Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory Disequilibrium in Stroke. Circulation Research. 2016;119(1):142-58.<Go to ISI>://WOS:000378496500017
7. Liu Q, Jin WN, Liu Y, Shi K, Sun H, Zhang F, et al. Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations. Immunity. 2017;46(3):474-87.https://www.ncbi.nlm.nih.gov/pubmed/28314594
8. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, Hwang SK, et al. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol. 2011;69(1):119-29.https://www.ncbi.nlm.nih.gov/pubmed/21280082
9. Tian DC, Shi K, Zhu Z, Yao J, Yang X, Su L, et al. Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow. Ann Neurol. 2018;84(5):717-28.https://www.ncbi.nlm.nih.gov/pubmed/30295338
10. Bobinger T, Manaenko A, Burkardt P, Beuscher V, Sprugel MI, Roeder SS, et al. Siponimod (BAF-312) Attenuates Perihemorrhagic Edema And Improves Survival in Experimental Intracerebral Hemorrhage. Stroke. 2019;50(11):3246-54.https://www.ncbi.nlm.nih.gov/pubmed/31558140
11. Schulze J, Gellrich J, Kirsch M, Dressel A, Vogelgesang A. Central Nervous System-Infiltrating T Lymphocytes in Stroke Are Activated via Their TCR (T-Cell Receptor) but Lack CD25 Expression. Stroke. 2021;52(9):2939-47.<Go to ISI>://WOS:000687824000040
12. Zera KA, Buckwalter MS. T cells direct microglial repair of white matter after stroke. Trends Neurosci. 2021.https://www.ncbi.nlm.nih.gov/pubmed/34332802
13. Dominguez-Villar M, Raddassi K, Danielsen AC, Guarnaccia J, Hafler DA. Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo. J Autoimmun. 2019;96:40-9.https://www.ncbi.nlm.nih.gov/pubmed/30122421
14. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci. 2008;28(46):12023-31.https://www.ncbi.nlm.nih.gov/pubmed/19005067
15. Ye XH, Wu Y, Guo PP, Wang J, Yuan SY, Shang Y, et al. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res. 2010;1323:174-83.https://www.ncbi.nlm.nih.gov/pubmed/20138164
16. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K. Microglia provide neuroprotection after ischemia. FASEB J. 2006;20(6):714-6.https://www.ncbi.nlm.nih.gov/pubmed/16473887
17. Deng Y, Chen D, Wang L, Gao F, Jin B, Lv H, et al. Silencing of Long Noncoding RNA Nespas Aggravates Microglial Cell Death and Neuroinflammation in Ischemic Stroke. Stroke. 2019;50(7):1850-8.https://www.ncbi.nlm.nih.gov/pubmed/31167620
18. Jadhav PK, Schiffler MA, Gavardinas K, Kim EJ, Matthews DP, Staszak MA, et al. Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm. ACS Med Chem Lett. 2014;5(10):1138-42.https://www.ncbi.nlm.nih.gov/pubmed/25313327
19. Cano-Gamez E, Soskic B, Roumeliotis TI, So E, Smyth DJ, Baldrighi M, et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4(+) T cells to cytokines. Nat Commun. 2020;11(1):1801.https://www.ncbi.nlm.nih.gov/pubmed/32286271
20. Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.https://www.ncbi.nlm.nih.gov/pubmed/28091601
21. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177(7):1888-902 e21.https://www.ncbi.nlm.nih.gov/pubmed/31178118
22. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009;4(1):44-57.https://www.ncbi.nlm.nih.gov/pubmed/19131956
23. Qiu X, Hill A, Packer J, Lin D, Ma YA, Trapnell C. Single-cell mRNA quantification and differential analysis with Census. Nature methods. 2017;14(3):309-15.https://www.ncbi.nlm.nih.gov/pubmed/28114287
24. Tao S, Jia M, Qiu T. Expression and role of CaMKII and Cx43 in a rat model of post-stroke depression. Exp Ther Med. 2019;18(3):2153-9.https://www.ncbi.nlm.nih.gov/pubmed/31410169
25. Zeng JX, Wang YM, Luo ZF, Chang LC, Yoo JS, Yang H, et al. TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotection upon Ischemic Stroke in Mice. Cell Reports. 2019;27(2):549-+.<Go to ISI>://WOS:000463894100019
26. Meng Z, Zhao T, Zhou K, Zhong Q, Wang Y, Xiong X, et al. A20 Ameliorates Intracerebral Hemorrhage-Induced Inflammatory Injury by Regulating TRAF6 Polyubiquitination. J Immunol. 2017;198(2):820-31.https://www.ncbi.nlm.nih.gov/pubmed/27986908
27. Xiong XY, Liu L, Wang FX, Yang YR, Hao JW, Wang PF, et al. Toll-Like Receptor 4/MyD88-Mediated Signaling of Hepcidin Expression Causing Brain Iron Accumulation, Oxidative Injury, and Cognitive Impairment After Intracerebral Hemorrhage. Circulation. 2016;134(14):1025-38.https://www.ncbi.nlm.nih.gov/pubmed/27576776
28. Ozen I, Roth M, Barbariga M, Gaceb A, Deierborg T, Genove G, et al. Loss of Regulator of G-Protein Signaling 5 Leads to Neurovascular Protection in Stroke. Stroke. 2018;49(9):2182-90.https://www.ncbi.nlm.nih.gov/pubmed/30354999
29. Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat Cell Biol. 2014;16(9):876-88.https://www.ncbi.nlm.nih.gov/pubmed/25086747
30. Chen SJ, Chen LH, Yeh YM, Lin CK, Lin PC, Huang HW, et al. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy. Theranostics. 2021;11(10):4672-87.https://www.ncbi.nlm.nih.gov/pubmed/33754020
31. Clark AK, Malcangio M. Microglial signalling mechanisms: Cathepsin S and Fractalkine. Exp Neurol. 2012;234(2):283-92.https://www.ncbi.nlm.nih.gov/pubmed/21946268
32. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008;32(2):200-19.https://www.ncbi.nlm.nih.gov/pubmed/18790057
33. Doherty DF, Nath S, Poon J, Foronjy RF, Ohlmeyer M, Dabo AJ, et al. Protein Phosphatase 2A Reduces Cigarette Smoke-induced Cathepsin S and Loss of Lung Function. Am J Respir Crit Care Med. 2019;200(1):51-62.https://www.ncbi.nlm.nih.gov/pubmed/30641028
34. Hughes CS, Colhoun LM, Bains BK, Kilgour JD, Burden RE, Burrows JF, et al. Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages. Part Fibre Toxicol. 2016;13:19.https://www.ncbi.nlm.nih.gov/pubmed/27108091
35. Seo Y, Kim HS, Kang I, Choi SW, Shin TH, Shin JH, et al. Cathepsin S Contributes to Microglia-Mediated Olfactory Dysfunction Through the Regulation of Cx3cl1-Cx3cr1 Axis in a Niemann-Pick Disease Type C1 Model. Glia. 2016;64(12):2291-305.<Go to ISI>://WOS:000386751100017
36. International Multiple Sclerosis Genetics C. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460).https://www.ncbi.nlm.nih.gov/pubmed/31604244
37. Gao Y, Li H, Li Z, Xie L, Liu X, Huang Z, et al. Single-Cell Analysis Reveals the Heterogeneity of Monocyte-Derived and Peripheral Type-2 Conventional Dendritic Cells. J Immunol. 2021;207(3):837-48.https://www.ncbi.nlm.nih.gov/pubmed/34282004
38. Xu H, Jia J. Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer's Disease. Front Immunol. 2021;12:645666.https://www.ncbi.nlm.nih.gov/pubmed/34447367
39. Huang Z, Chen B, Liu X, Li H, Xie L, Gao Y, et al. Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proc Natl Acad Sci U S A. 2021;118(33).https://www.ncbi.nlm.nih.gov/pubmed/34385315
40. van Dalen FJ, Bakkum T, van Leeuwen T, Groenewold M, Deu E, Koster AJ, et al. Application of a Highly Selective Cathepsin S Two-step Activity-Based Probe in Multicolor Bio-Orthogonal Correlative Light-Electron Microscopy. Front Chem. 2020;8:628433.https://www.ncbi.nlm.nih.gov/pubmed/33644004
41. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, et al. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity. 1999;10(2):197-206.https://www.ncbi.nlm.nih.gov/pubmed/10072072
42. Kim SJ, Schatzle S, Ahmed SS, Haap W, Jang SH, Gregersen PK, et al. Increased cathepsin S in Prdm1(-/-) dendritic cells alters the TFH cell repertoire and contributes to lupus. Nat Immunol. 2017;18(9):1016-24.https://www.ncbi.nlm.nih.gov/pubmed/28692065
43. Baugh M, Black D, Westwood P, Kinghorn E, McGregor K, Bruin J, et al. Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity. J Autoimmun. 2011;36(3-4):201-9.https://www.ncbi.nlm.nih.gov/pubmed/21439785
44. Sena BF, Figueiredo JL, Aikawa E. Cathepsin S As an inhibitor of Cardiovascular inflammation and Calcification in Chronic Kidney Disease. Front Cardiovasc Med. 2018;4.<Go to ISI>://WOS:000426132700001
45. Wilkinson RD, Young A, Burden RE, Williams R, Scott CJ. A bioavailable cathepsin S nitrile inhibitor abrogates tumor development. Mol Cancer. 2016;15:29.https://www.ncbi.nlm.nih.gov/pubmed/27097645
46. Vasiljeva O, Dolinar M, Pungercar JR, Turk V, Turk B. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans. Febs Lett. 2005;579(5):1285-90.<Go to ISI>://WOS:000227210600052
47. Jia W, Martin TA, Zhang G, Jiang WG. Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis. Anticancer Res. 2013;33(6):2353-9.https://www.ncbi.nlm.nih.gov/pubmed/23749882
48. Liu WY, Wang ZB, Zhang LC, Wei X, Li L. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances. CNS Neurosci Ther. 2012;18(8):609-15.https://www.ncbi.nlm.nih.gov/pubmed/22686334
49. Ludewig P, Sedlacik J, Gelderblom M, Bernreuther C, Korkusuz Y, Wagener C, et al. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke. Circ Res. 2013;113(8):1013-22.https://www.ncbi.nlm.nih.gov/pubmed/23780386
50. Abdul-Muneer PM, Schuetz H, Wang F, Skotak M, Jones J, Gorantla S, et al. Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med. 2013;60:282-91.https://www.ncbi.nlm.nih.gov/pubmed/23466554
51. Chen F, Ohashi N, Li W, Eckman C, Nguyen JH. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology. 2009;50(6):1914-23.https://www.ncbi.nlm.nih.gov/pubmed/19821483
52. Yang Y, Estrada EY, Thompson JF, Liu WL, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cerebr Blood F Met. 2007;27(4):697-709.<Go to ISI>://WOS:000245358800005
53. Hua D, Tang L, Wang W, Tang S, Yu L, Zhou X, et al. Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide. Adv Sci (Weinh). 2021;8(3):2001960.https://www.ncbi.nlm.nih.gov/pubmed/33552853